Skip to main content

Proceeding contribution from Ann Keen (Labour) in the House of Commons on Tuesday, 19 January 2010. It occurred during Adjournment debate on Musculoskeletal Conditions.


Musculoskeletal Conditions

I want to begin by congratulating the hon. Member for Rochdale (Paul Rowen) on securing the debate. I would also like to add my own tribute to you, Mr. Streeter, as we serve under your chairmanship today. I want to acknowledge the gallant leadership that has been shown by the nurse sitting opposite me today: the hon. Member for Guildford (Anne Milton). In this debate, of course, we have heard from two nurses, in the hon. Lady and myself; a physician, the hon. Member for Wyre Forest (Dr. Taylor); and a scientist, my hon. Friend the Member for Manchester, Blackley (Graham Stringer). I am not sure about some of the attributes that other hon. Members present have brought to the debate, along with their concern for their constituents, but they have been able to demonstrate their abilities and interests in this area. I also congratulate the hon. Member for Rochdale on his relationship, as a trustee, with the Arthritis Research Campaign. I applaud the imaginative title of "Joint Working?", the Arthritis and Musculoskeletal Alliance report to which that he referred. Before I address in detail the concerns that the hon. Gentleman and other hon. Members have raised, I would like to recognise the excellent work of NHS staff that is taking place across the whole of Rochdale. Those staff are delivering a better quality health service than ever, which benefits the hon. Gentleman's constituents and those of other hon. Members. It is estimated that nearly a quarter of adults and about 12,000 children are affected by long-standing musculoskeletal problems—with your permission, Mr. Streeter, I will refer to musculoskeletal as "MSK" throughout the rest of my speech. MSK conditions, such as rheumatoid arthritis, osteoporosis and other bone, joint, spinal and muscular diseases, can cause tremendous pain and anxiety to sufferers and their families on a daily basis. When someone sees their GP with a suspected MSK problem, there is often no single diagnostic test that can confirm a particular condition, because symptoms can vary, as was set out earlier in the debate. For example, the symptoms of rheumatoid arthritis are similar to many more common conditions. The hon. Member for Wyre Forest gave a very good description of the symptoms that people might experience when they awake from sleep. As he did so, I looked around the Chamber and I could see Members and officials perhaps thinking, "Was that how I felt this morning?", as they awoke with stiffness and swelling of joints. It is very common for us to feel that anxiety about such symptoms with which we struggle in many areas of our life. Of course, "struggle" is what most people do if they have any of these conditions. Early diagnosis of these debilitating conditions is essential, because if treatment is started early, the damage to joints can be minimised. There is an increasing amount of evidence that aggressive treatment soon after the onset of symptoms can lead to remission. Hon. Members have quite rightly raised the issue of why some primary care trusts fund GPs with specialist interests while other PCTs do not. Some PCTs have alternatives to GPs with specialist interests. For example, we now have consultant-led teams working in the community and, as has been mentioned already, we also have nurse-led clinics that have access to a consultant. For example, the Pennine MSK partnership in Oldham adopts a community-based approach. Norfolk and Norwich University Hospitals NHS Foundation Trust co-ordinates care between hospital departments, and GPs and nurses in the community. Of course, the very important physiotherapists and occupational therapists also play their role. As is the case with so many long-term conditions, there will now be a team approach to MSK conditions. PCTs need to decide how best to provide services with their local populations. Commissioning is exceptionally important. World-class commissioning will help PCTs to align their more strategic priorities with the key health outcomes that will deliver for their particular local population. PCTs need to ensure that they commission the services that are needed for their patients. In the Department of Health, we continue to work closely with key stakeholders to share this learning, because learning is what we are doing. We are learning how to treat long-term conditions of a very difficult—often chronic—nature together in the community. Therefore, good practice must be shared.


Secondary information

Type
Proceeding contribution
Reference
504 c16-7WH 
Session
2009-10
Chamber / Committee
Westminster Hall
Subjects
Health services Finance Diseases Medical treatments Research Arthritis Musculoskeletal disorders Arthritis and Musculoskeletal Alliance
Link
View this Proceeding contribution on www.publications.parliament.uk